Literature DB >> 11681630

Co-administration of dextromethorphan during pregnancy and throughout lactation significantly decreases the adverse effects associated with chronic morphine administration in rat offspring.

P L Tao1, G C Yeh, C H Su, Y H Wu.   

Abstract

In this study, we have focused our investigation of the facts whether co-administration of a NMDA antagonist dextromethorphan (DM) with morphine during pregnancy and throughout lactation could prevent the adverse effects associated with chronic morphine administration in rat offspring. Adult female Sprague-Dawley rats were randomly separated into four groups and were received subcutaneous injection of either saline, morphine, morphine + dextromethorphan or dextromethorphan twice a day and progressively increased 1 mg/kg at 7-day intervals from a beginning dose of 2 mg/kg for both morphine and dextromethorphan. The rats were mated between days 7 and 8. Administration of drugs was continued during pregnancy. After rat offspring were born, the doses of morphine or dextromethorphan injected into the maternal rats were increased by 1 mg/kg every two weeks till the offspring were 30 day old. The results showed that mortality of morphine group is much higher than control group. The offspring of morphine group weighed significantly less than control group on postnatal day 14 (p14), p30 or p60. The antinociceptive effect of morphine on p14 rats was reduced in the morphine group and indicated the development of morphine tolerance. The hippocampal NMDA receptor densities have been shown decreased on p14 rats. The precipitated withdrawal symptoms were assessed on p7 rats. Rats in morphine group showed greater frequency of abdominal stretch and wet dog shake in 2 hr than control group. On the other hand, co-administration of DM with morphine effectively prevented all these adverse effects of morphine to the offspring rats. DM co-administered with morphine also partially prevented the development of morphine tolerance in maternal rats. If this effect of dextromethorphan is applied to clinical pregnant patients with morphine addiction or chronic pain, it will have a great value for the benefit of their children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681630     DOI: 10.1016/s0024-3205(01)01316-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Prenatal oxycodone exposure impairs spatial learning and/or memory in rats.

Authors:  Chris P Davis; La'tonya M Franklin; Gabriel S Johnson; Lisa M Schrott
Journal:  Behav Brain Res       Date:  2010-03-20       Impact factor: 3.332

2.  Enhancement of tolerance development to morphine in rats prenatally exposed to morphine, methadone, and buprenorphine.

Authors:  Yao-Chang Chiang; Tsai-Wei Hung; Cynthia Wei-Sheng Lee; Jia-Ying Yan; Ing-Kang Ho
Journal:  J Biomed Sci       Date:  2010-06-07       Impact factor: 8.410

3.  Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.

Authors:  Eagle Y-K Huang; Te-Chen Liu; Pao-Luh Tao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-15       Impact factor: 3.000

4.  Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training.

Authors:  Lisa M Schrott; La 'Tonya M Franklin; Peter A Serrano
Journal:  Brain Res       Date:  2008-01-18       Impact factor: 3.252

5.  Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software.

Authors:  Hanna J Kulbeth; Saki Fukuda; Lisa K Brents
Journal:  Neurotoxicol Teratol       Date:  2021-01-30       Impact factor: 3.763

6.  Dextromethorphan attenuated the higher vulnerability to inflammatory thermal hyperalgesia caused by prenatal morphine exposure in rat offspring.

Authors:  Pao-Luh Tao; Chien-Fang Chen; Eagle Yi-Kung Huang
Journal:  J Biomed Sci       Date:  2011-08-23       Impact factor: 8.410

7.  Beneficial effects of co-treatment with dextromethorphan on prenatally methadone-exposed offspring.

Authors:  Yao-Chang Chiang; Li-Ci Ye; Kuei-Ying Hsu; Chien-Wei Liao; Tsai-Wei Hung; Wan-Jou Lo; Ing-Kang Ho; Pao-Luh Tao
Journal:  J Biomed Sci       Date:  2015-03-20       Impact factor: 8.410

8.  Attenuation by dextromethorphan on the higher liability to morphine-induced reward, caused by prenatal exposure of morphine in rat offspring.

Authors:  Ling-Yi Wu; Jain-Fang Chen; Pao-Luh Tao; Eagle Yi-Kung Huang
Journal:  J Biomed Sci       Date:  2009-11-25       Impact factor: 8.410

9.  Enduring consequences of perinatal fentanyl exposure in mice.

Authors:  Jason B Alipio; Adam T Brockett; Megan E Fox; Stephen S Tennyson; Coreylyn A deBettencourt; Dina El-Metwally; Nikolas A Francis; Patrick O Kanold; Mary Kay Lobo; Matthew R Roesch; Asaf Keller
Journal:  Addict Biol       Date:  2020-03-18       Impact factor: 4.280

10.  Effects of perinatal oxycodone exposure on the cardiovascular response to acute stress in male rats at weaning and in young adulthood.

Authors:  Thitinart Sithisarn; Henrietta S Bada; Richard J Charnigo; Sandra J Legan; David C Randall
Journal:  Front Physiol       Date:  2013-04-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.